img

Global Electrocompetent Cells Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Electrocompetent Cells Market Insights, Forecast to 2034

Electrocompetent cells work using the electroporation process. Electrical pulses created pores that allows genetic material to permeate the bacterial membrane. Invitrogen offers a variety of electrocompetent E. coli cells to reliably clone your DNA with high efficiency.
Market Analysis and InsightsGlobal Electrocompetent Cells Market
Global Electrocompetent Cells market is expected to reach to US$ 774.7 million in 2023, with a positive growth of %, compared with US$ 713.7 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Electrocompetent Cells industry is evaluated to reach US$ 1335.4 million in 2033. The CAGR will be 9.5% during 2023 to 2033.
Globally, Electrocompetent Cells key companies include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech and New England Biolabs, etc. Merck KGaA, Thermo Fisher Scientific, Agilent Technologies are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Electrocompetent Cells were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Electrocompetent Cells market and estimated to attract more attentions from industry insiders and investors.
Electrocompetent Cells can be divided into Cloned Competent Cells, Agrobacterium tumefaciens Competent Cells and Expression Competent Cells,, etc. Cloned Competent Cells is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Electrocompetent Cells is widely used in various fields, such as Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable Dna Cloning and High-Throughput Cloning, etc. Subcloning & Routine Cloning provides greatest supports to the Electrocompetent Cells industry development. In 2022, global % revenue of Electrocompetent Cells went into Subcloning & Routine Cloning filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Electrocompetent Cells market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Electrocompetent Cells market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
Segment by Type
Cloned Competent Cells
Agrobacterium tumefaciens Competent Cells
Expression Competent Cells

Segment by Application


Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable Dna Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded Dna Production
Bacmid creation
Cre-lox recombination (PIR1/PIR2)
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Electrocompetent Cells introduction, etc. Electrocompetent Cells Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Electrocompetent Cells
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Electrocompetent Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Cloned Competent Cells
1.2.3 Agrobacterium tumefaciens Competent Cells
1.2.4 Expression Competent Cells
1.3 Market by Application
1.3.1 Global Electrocompetent Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Subcloning & Routine Cloning
1.3.3 Phage Display Library Construction
1.3.4 Toxic/Unstable Dna Cloning
1.3.5 High-Throughput Cloning
1.3.6 Protein Expression
1.3.7 Mutagenesis
1.3.8 Single-Stranded Dna Production
1.3.9 Bacmid creation
1.3.10 Cre-lox recombination (PIR1/PIR2)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Electrocompetent Cells Market Perspective (2018-2033)
2.2 Global Electrocompetent Cells Growth Trends by Region
2.2.1 Electrocompetent Cells Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Electrocompetent Cells Historic Market Size by Region (2018-2023)
2.2.3 Electrocompetent Cells Forecasted Market Size by Region (2024-2033)
2.3 Electrocompetent Cells Market Dynamics
2.3.1 Electrocompetent Cells Industry Trends
2.3.2 Electrocompetent Cells Market Drivers
2.3.3 Electrocompetent Cells Market Challenges
2.3.4 Electrocompetent Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Electrocompetent Cells by Players
3.1.1 Global Electrocompetent Cells Revenue by Players (2018-2023)
3.1.2 Global Electrocompetent Cells Revenue Market Share by Players (2018-2023)
3.2 Global Electrocompetent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Electrocompetent Cells, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Electrocompetent Cells Market Concentration Ratio
3.4.1 Global Electrocompetent Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Electrocompetent Cells Revenue in 2022
3.5 Global Key Players of Electrocompetent Cells Head office and Area Served
3.6 Global Key Players of Electrocompetent Cells, Product and Application
3.7 Global Key Players of Electrocompetent Cells, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Electrocompetent Cells Breakdown Data by Type
4.1 Global Electrocompetent Cells Historic Market Size by Type (2018-2023)
4.2 Global Electrocompetent Cells Forecasted Market Size by Type (2024-2033)
5 Electrocompetent Cells Breakdown Data by Application
5.1 Global Electrocompetent Cells Historic Market Size by Application (2018-2023)
5.2 Global Electrocompetent Cells Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Electrocompetent Cells Market Size (2018-2033)
6.2 North America Electrocompetent Cells Market Size by Type
6.2.1 North America Electrocompetent Cells Market Size by Type (2018-2023)
6.2.2 North America Electrocompetent Cells Market Size by Type (2024-2033)
6.2.3 North America Electrocompetent Cells Market Share by Type (2018-2033)
6.3 North America Electrocompetent Cells Market Size by Application
6.3.1 North America Electrocompetent Cells Market Size by Application (2018-2023)
6.3.2 North America Electrocompetent Cells Market Size by Application (2024-2033)
6.3.3 North America Electrocompetent Cells Market Share by Application (2018-2033)
6.4 North America Electrocompetent Cells Market Size by Country
6.4.1 North America Electrocompetent Cells Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Electrocompetent Cells Market Size by Country (2018-2023)
6.4.3 North America Electrocompetent Cells Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Electrocompetent Cells Market Size (2018-2033)
7.2 Europe Electrocompetent Cells Market Size by Type
7.2.1 Europe Electrocompetent Cells Market Size by Type (2018-2023)
7.2.2 Europe Electrocompetent Cells Market Size by Type (2024-2033)
7.2.3 Europe Electrocompetent Cells Market Share by Type (2018-2033)
7.3 Europe Electrocompetent Cells Market Size by Application
7.3.1 Europe Electrocompetent Cells Market Size by Application (2018-2023)
7.3.2 Europe Electrocompetent Cells Market Size by Application (2024-2033)
7.3.3 Europe Electrocompetent Cells Market Share by Application (2018-2033)
7.4 Europe Electrocompetent Cells Market Size by Country
7.4.1 Europe Electrocompetent Cells Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Electrocompetent Cells Market Size by Country (2018-2023)
7.4.3 Europe Electrocompetent Cells Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Electrocompetent Cells Market Size (2018-2033)
8.2 China Electrocompetent Cells Market Size by Type
8.2.1 China Electrocompetent Cells Market Size by Type (2018-2023)
8.2.2 China Electrocompetent Cells Market Size by Type (2024-2033)
8.2.3 China Electrocompetent Cells Market Share by Type (2018-2033)
8.3 China Electrocompetent Cells Market Size by Application
8.3.1 China Electrocompetent Cells Market Size by Application (2018-2023)
8.3.2 China Electrocompetent Cells Market Size by Application (2024-2033)
8.3.3 China Electrocompetent Cells Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Electrocompetent Cells Market Size (2018-2033)
9.2 Asia Electrocompetent Cells Market Size by Type
9.2.1 Asia Electrocompetent Cells Market Size by Type (2018-2023)
9.2.2 Asia Electrocompetent Cells Market Size by Type (2024-2033)
9.2.3 Asia Electrocompetent Cells Market Share by Type (2018-2033)
9.3 Asia Electrocompetent Cells Market Size by Application
9.3.1 Asia Electrocompetent Cells Market Size by Application (2018-2023)
9.3.2 Asia Electrocompetent Cells Market Size by Application (2024-2033)
9.3.3 Asia Electrocompetent Cells Market Share by Application (2018-2033)
9.4 Asia Electrocompetent Cells Market Size by Region
9.4.1 Asia Electrocompetent Cells Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Electrocompetent Cells Market Size by Region (2018-2023)
9.4.3 Asia Electrocompetent Cells Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Electrocompetent Cells Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Type
10.2.1 Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Electrocompetent Cells Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Application
10.3.1 Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Electrocompetent Cells Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Country
10.4.1 Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Details
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Electrocompetent Cells Introduction
11.1.4 Merck KGaA Revenue in Electrocompetent Cells Business (2018-2023)
11.1.5 Merck KGaA Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Electrocompetent Cells Introduction
11.2.4 Thermo Fisher Scientific Revenue in Electrocompetent Cells Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Electrocompetent Cells Introduction
11.3.4 Agilent Technologies Revenue in Electrocompetent Cells Business (2018-2023)
11.3.5 Agilent Technologies Recent Developments
11.4 Takara Bio
11.4.1 Takara Bio Company Details
11.4.2 Takara Bio Business Overview
11.4.3 Takara Bio Electrocompetent Cells Introduction
11.4.4 Takara Bio Revenue in Electrocompetent Cells Business (2018-2023)
11.4.5 Takara Bio Recent Developments
11.5 Promega Corporation
11.5.1 Promega Corporation Company Details
11.5.2 Promega Corporation Business Overview
11.5.3 Promega Corporation Electrocompetent Cells Introduction
11.5.4 Promega Corporation Revenue in Electrocompetent Cells Business (2018-2023)
11.5.5 Promega Corporation Recent Developments
11.6 Beijing TransGen Biotech
11.6.1 Beijing TransGen Biotech Company Details
11.6.2 Beijing TransGen Biotech Business Overview
11.6.3 Beijing TransGen Biotech Electrocompetent Cells Introduction
11.6.4 Beijing TransGen Biotech Revenue in Electrocompetent Cells Business (2018-2023)
11.6.5 Beijing TransGen Biotech Recent Developments
11.7 GeneScript Corporation
11.7.1 GeneScript Corporation Company Details
11.7.2 GeneScript Corporation Business Overview
11.7.3 GeneScript Corporation Electrocompetent Cells Introduction
11.7.4 GeneScript Corporation Revenue in Electrocompetent Cells Business (2018-2023)
11.7.5 GeneScript Corporation Recent Developments
11.8 Yeastern Biotech
11.8.1 Yeastern Biotech Company Details
11.8.2 Yeastern Biotech Business Overview
11.8.3 Yeastern Biotech Electrocompetent Cells Introduction
11.8.4 Yeastern Biotech Revenue in Electrocompetent Cells Business (2018-2023)
11.8.5 Yeastern Biotech Recent Developments
11.9 New England Biolabs
11.9.1 New England Biolabs Company Details
11.9.2 New England Biolabs Business Overview
11.9.3 New England Biolabs Electrocompetent Cells Introduction
11.9.4 New England Biolabs Revenue in Electrocompetent Cells Business (2018-2023)
11.9.5 New England Biolabs Recent Developments
11.10 QIAGEN N.V.
11.10.1 QIAGEN N.V. Company Details
11.10.2 QIAGEN N.V. Business Overview
11.10.3 QIAGEN N.V. Electrocompetent Cells Introduction
11.10.4 QIAGEN N.V. Revenue in Electrocompetent Cells Business (2018-2023)
11.10.5 QIAGEN N.V. Recent Developments
11.11 OriGene Technologies
11.11.1 OriGene Technologies Company Details
11.11.2 OriGene Technologies Business Overview
11.11.3 OriGene Technologies Electrocompetent Cells Introduction
11.11.4 OriGene Technologies Revenue in Electrocompetent Cells Business (2018-2023)
11.11.5 OriGene Technologies Recent Developments
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Electrocompetent Cells Introduction
11.12.4 Lucigen Revenue in Electrocompetent Cells Business (2018-2023)
11.12.5 Lucigen Recent Developments
11.13 Zymo Research
11.13.1 Zymo Research Company Details
11.13.2 Zymo Research Business Overview
11.13.3 Zymo Research Electrocompetent Cells Introduction
11.13.4 Zymo Research Revenue in Electrocompetent Cells Business (2018-2023)
11.13.5 Zymo Research Recent Developments
11.14 Bio-Rad Laboratories
11.14.1 Bio-Rad Laboratories Company Details
11.14.2 Bio-Rad Laboratories Business Overview
11.14.3 Bio-Rad Laboratories Electrocompetent Cells Introduction
11.14.4 Bio-Rad Laboratories Revenue in Electrocompetent Cells Business (2018-2023)
11.14.5 Bio-Rad Laboratories Recent Developments
11.15 Bioline
11.15.1 Bioline Company Details
11.15.2 Bioline Business Overview
11.15.3 Bioline Electrocompetent Cells Introduction
11.15.4 Bioline Revenue in Electrocompetent Cells Business (2018-2023)
11.15.5 Bioline Recent Developments
11.16 Delphi Genetics
11.16.1 Delphi Genetics Company Details
11.16.2 Delphi Genetics Business Overview
11.16.3 Delphi Genetics Electrocompetent Cells Introduction
11.16.4 Delphi Genetics Revenue in Electrocompetent Cells Business (2018-2023)
11.16.5 Delphi Genetics Recent Developments
11.17 IBA GmBH
11.17.1 IBA GmBH Company Details
11.17.2 IBA GmBH Business Overview
11.17.3 IBA GmBH Electrocompetent Cells Introduction
11.17.4 IBA GmBH Revenue in Electrocompetent Cells Business (2018-2023)
11.17.5 IBA GmBH Recent Developments
11.18 Cell Applications
11.18.1 Cell Applications Company Details
11.18.2 Cell Applications Business Overview
11.18.3 Cell Applications Electrocompetent Cells Introduction
11.18.4 Cell Applications Revenue in Electrocompetent Cells Business (2018-2023)
11.18.5 Cell Applications Recent Developments
11.19 BioDynamics Laboratory
11.19.1 BioDynamics Laboratory Company Details
11.19.2 BioDynamics Laboratory Business Overview
11.19.3 BioDynamics Laboratory Electrocompetent Cells Introduction
11.19.4 BioDynamics Laboratory Revenue in Electrocompetent Cells Business (2018-2023)
11.19.5 BioDynamics Laboratory Recent Developments
11.20 Scarab Genomics
11.20.1 Scarab Genomics Company Details
11.20.2 Scarab Genomics Business Overview
11.20.3 Scarab Genomics Electrocompetent Cells Introduction
11.20.4 Scarab Genomics Revenue in Electrocompetent Cells Business (2018-2023)
11.20.5 Scarab Genomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Electrocompetent Cells Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Cloned Competent Cells
Table 3. Key Players of Agrobacterium tumefaciens Competent Cells
Table 4. Key Players of Expression Competent Cells
Table 5. Global Electrocompetent Cells Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Electrocompetent Cells Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Electrocompetent Cells Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Electrocompetent Cells Market Share by Region (2018-2023)
Table 9. Global Electrocompetent Cells Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Electrocompetent Cells Market Share by Region (2024-2033)
Table 11. Electrocompetent Cells Market Trends
Table 12. Electrocompetent Cells Market Drivers
Table 13. Electrocompetent Cells Market Challenges
Table 14. Electrocompetent Cells Market Restraints
Table 15. Global Electrocompetent Cells Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Electrocompetent Cells Revenue Share by Players (2018-2023)
Table 17. Global Top Electrocompetent Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Electrocompetent Cells as of 2022)
Table 18. Global Electrocompetent Cells Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Electrocompetent Cells Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Electrocompetent Cells, Headquarters and Area Served
Table 21. Global Key Players of Electrocompetent Cells, Product and Application
Table 22. Global Key Players of Electrocompetent Cells, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Electrocompetent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Electrocompetent Cells Revenue Market Share by Type (2018-2023)
Table 26. Global Electrocompetent Cells Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Electrocompetent Cells Revenue Market Share by Type (2024-2033)
Table 28. Global Electrocompetent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Electrocompetent Cells Revenue Share by Application (2018-2023)
Table 30. Global Electrocompetent Cells Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Electrocompetent Cells Revenue Share by Application (2024-2033)
Table 32. North America Electrocompetent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Electrocompetent Cells Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Electrocompetent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Electrocompetent Cells Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Electrocompetent Cells Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Electrocompetent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Electrocompetent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Electrocompetent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Electrocompetent Cells Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Electrocompetent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Electrocompetent Cells Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Electrocompetent Cells Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Electrocompetent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Electrocompetent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Electrocompetent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Electrocompetent Cells Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Electrocompetent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Electrocompetent Cells Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Electrocompetent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Electrocompetent Cells Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Electrocompetent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Electrocompetent Cells Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Electrocompetent Cells Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Electrocompetent Cells Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Electrocompetent Cells Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Electrocompetent Cells Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Electrocompetent Cells Market Size by Country (2024-2033) & (US$ Million)
Table 64. Merck KGaA Company Details
Table 65. Merck KGaA Business Overview
Table 66. Merck KGaA Electrocompetent Cells Product
Table 67. Merck KGaA Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 68. Merck KGaA Recent Developments
Table 69. Thermo Fisher Scientific Company Details
Table 70. Thermo Fisher Scientific Business Overview
Table 71. Thermo Fisher Scientific Electrocompetent Cells Product
Table 72. Thermo Fisher Scientific Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 73. Thermo Fisher Scientific Recent Developments
Table 74. Agilent Technologies Company Details
Table 75. Agilent Technologies Business Overview
Table 76. Agilent Technologies Electrocompetent Cells Product
Table 77. Agilent Technologies Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 78. Agilent Technologies Recent Developments
Table 79. Takara Bio Company Details
Table 80. Takara Bio Business Overview
Table 81. Takara Bio Electrocompetent Cells Product
Table 82. Takara Bio Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 83. Takara Bio Recent Developments
Table 84. Promega Corporation Company Details
Table 85. Promega Corporation Business Overview
Table 86. Promega Corporation Electrocompetent Cells Product
Table 87. Promega Corporation Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 88. Promega Corporation Recent Developments
Table 89. Beijing TransGen Biotech Company Details
Table 90. Beijing TransGen Biotech Business Overview
Table 91. Beijing TransGen Biotech Electrocompetent Cells Product
Table 92. Beijing TransGen Biotech Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 93. Beijing TransGen Biotech Recent Developments
Table 94. GeneScript Corporation Company Details
Table 95. GeneScript Corporation Business Overview
Table 96. GeneScript Corporation Electrocompetent Cells Product
Table 97. GeneScript Corporation Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 98. GeneScript Corporation Recent Developments
Table 99. Yeastern Biotech Company Details
Table 100. Yeastern Biotech Business Overview
Table 101. Yeastern Biotech Electrocompetent Cells Product
Table 102. Yeastern Biotech Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 103. Yeastern Biotech Recent Developments
Table 104. New England Biolabs Company Details
Table 105. New England Biolabs Business Overview
Table 106. New England Biolabs Electrocompetent Cells Product
Table 107. New England Biolabs Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 108. New England Biolabs Recent Developments
Table 109. QIAGEN N.V. Company Details
Table 110. QIAGEN N.V. Business Overview
Table 111. QIAGEN N.V. Electrocompetent Cells Product
Table 112. QIAGEN N.V. Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 113. QIAGEN N.V. Recent Developments
Table 114. OriGene Technologies Company Details
Table 115. OriGene Technologies Business Overview
Table 116. OriGene Technologies Electrocompetent Cells Product
Table 117. OriGene Technologies Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 118. OriGene Technologies Recent Developments
Table 119. Lucigen Company Details
Table 120. Lucigen Business Overview
Table 121. Lucigen Electrocompetent Cells Product
Table 122. Lucigen Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 123. Lucigen Recent Developments
Table 124. Zymo Research Company Details
Table 125. Zymo Research Business Overview
Table 126. Zymo Research Electrocompetent Cells Product
Table 127. Zymo Research Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 128. Zymo Research Recent Developments
Table 129. Bio-Rad Laboratories Company Details
Table 130. Bio-Rad Laboratories Business Overview
Table 131. Bio-Rad Laboratories Electrocompetent Cells Product
Table 132. Bio-Rad Laboratories Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 133. Bio-Rad Laboratories Recent Developments
Table 134. Bioline Company Details
Table 135. Bioline Business Overview
Table 136. Bioline Electrocompetent Cells Product
Table 137. Bioline Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 138. Bioline Recent Developments
Table 139. Delphi Genetics Company Details
Table 140. Delphi Genetics Business Overview
Table 141. Delphi Genetics Electrocompetent Cells Product
Table 142. Delphi Genetics Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 143. Delphi Genetics Recent Developments
Table 144. IBA GmBH Company Details
Table 145. IBA GmBH Business Overview
Table 146. IBA GmBH Electrocompetent Cells Product
Table 147. IBA GmBH Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 148. IBA GmBH Recent Developments
Table 149. Cell Applications Company Details
Table 150. Cell Applications Business Overview
Table 151. Cell Applications Electrocompetent Cells Product
Table 152. Cell Applications Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 153. Cell Applications Recent Developments
Table 154. BioDynamics Laboratory Company Details
Table 155. BioDynamics Laboratory Business Overview
Table 156. BioDynamics Laboratory Electrocompetent Cells Product
Table 157. BioDynamics Laboratory Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 158. BioDynamics Laboratory Recent Developments
Table 159. Scarab Genomics Company Details
Table 160. Scarab Genomics Business Overview
Table 161. Scarab Genomics Electrocompetent Cells Product
Table 162. Scarab Genomics Revenue in Electrocompetent Cells Business (2018-2023) & (US$ Million)
Table 163. Scarab Genomics Recent Developments
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Electrocompetent Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Electrocompetent Cells Market Share by Type: 2022 VS 2033
Figure 3. Cloned Competent Cells Features
Figure 4. Agrobacterium tumefaciens Competent Cells Features
Figure 5. Expression Competent Cells Features
Figure 6. Global Electrocompetent Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Electrocompetent Cells Market Share by Application: 2022 VS 2033
Figure 8. Subcloning & Routine Cloning Case Studies
Figure 9. Phage Display Library Construction Case Studies
Figure 10. Toxic/Unstable Dna Cloning Case Studies
Figure 11. High-Throughput Cloning Case Studies
Figure 12. Protein Expression Case Studies
Figure 13. Mutagenesis Case Studies
Figure 14. Single-Stranded Dna Production Case Studies
Figure 15. Bacmid creation Case Studies
Figure 16. Cre-lox recombination (PIR1/PIR2) Case Studies
Figure 17. Electrocompetent Cells Report Years Considered
Figure 18. Global Electrocompetent Cells Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 19. Global Electrocompetent Cells Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 20. Global Electrocompetent Cells Market Share by Region: 2022 VS 2033
Figure 21. Global Electrocompetent Cells Market Share by Players in 2022
Figure 22. Global Top Electrocompetent Cells Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Electrocompetent Cells as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by Electrocompetent Cells Revenue in 2022
Figure 24. North America Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. North America Electrocompetent Cells Market Share by Type (2018-2033)
Figure 26. North America Electrocompetent Cells Market Share by Application (2018-2033)
Figure 27. North America Electrocompetent Cells Market Share by Country (2018-2033)
Figure 28. United States Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Canada Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Europe Electrocompetent Cells Market Size YoY (2018-2033) & (US$ Million)
Figure 31. Europe Electrocompetent Cells Market Share by Type (2018-2033)
Figure 32. Europe Electrocompetent Cells Market Share by Application (2018-2033)
Figure 33. Europe Electrocompetent Cells Market Share by Country (2018-2033)
Figure 34. Germany Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. France Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. U.K. Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Italy Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Russia Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Nordic Countries Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. China Electrocompetent Cells Market Size YoY (2018-2033) & (US$ Million)
Figure 41. China Electrocompetent Cells Market Share by Type (2018-2033)
Figure 42. China Electrocompetent Cells Market Share by Application (2018-2033)
Figure 43. Asia Electrocompetent Cells Market Size YoY (2018-2033) & (US$ Million)
Figure 44. Asia Electrocompetent Cells Market Share by Type (2018-2033)
Figure 45. Asia Electrocompetent Cells Market Share by Application (2018-2033)
Figure 46. Asia Electrocompetent Cells Market Share by Region (2018-2033)
Figure 47. Japan Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. South Korea Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. China Taiwan Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. India Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Australia Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Middle East, Africa, and Latin America Electrocompetent Cells Market Size YoY (2018-2033) & (US$ Million)
Figure 54. Middle East, Africa, and Latin America Electrocompetent Cells Market Share by Type (2018-2033)
Figure 55. Middle East, Africa, and Latin America Electrocompetent Cells Market Share by Application (2018-2033)
Figure 56. Middle East, Africa, and Latin America Electrocompetent Cells Market Share by Country (2018-2033)
Figure 57. Brazil Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Mexico Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Turkey Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Saudi Arabia Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 61. Israel Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 62. GCC Countries Electrocompetent Cells Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 63. Merck KGaA Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 64. Thermo Fisher Scientific Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 65. Agilent Technologies Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 66. Takara Bio Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 67. Promega Corporation Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 68. Beijing TransGen Biotech Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 69. GeneScript Corporation Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 70. Yeastern Biotech Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 71. New England Biolabs Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 72. QIAGEN N.V. Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 73. OriGene Technologies Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 74. Lucigen Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 75. Zymo Research Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 76. Bio-Rad Laboratories Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 77. Bioline Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 78. Delphi Genetics Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 79. IBA GmBH Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 80. Cell Applications Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 81. BioDynamics Laboratory Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 82. Scarab Genomics Revenue Growth Rate in Electrocompetent Cells Business (2018-2023)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed